PTC Therapeutics

Press Releases

The press releases contained in this archive section are provided for historical purposes only. The information contained in each press release is accurate only as of the date each press release was originally issued. PTC Therapeutics disavows any obligation to update the information contained in such press releases after the date of their issuance.

Date Title and Summary View
Feb 10, 2014
PTC Therapeutics Announces Proposed Public Offering of Common Stock SOUTH PLAINFIELD, NJ – February 10, 2014 – PTC Therapeutics, Inc. (NASDAQ: PTCT) announced today that it has commenced an underwritten public offering of approximately $75 million of shares of its common stock.
Additional Formats
Jan 30, 2014
  SOUTH PLAINFIELD, NJ – January 30, 2014 – PTC Therapeutics, Inc. (NASDAQ: PTCT) is proud to announce that its founder and Chief Executive Officer, Stuart W. Peltz, Ph.D., has been awarded the 2014 Dr. Sol J. Barer Award for Vision, Innovation, and Leadership. Named for Sol J.
Additional Formats
Jan 24, 2014
PTC THERAPEUTICS PROVIDES UPDATE ON CHMP OPINION FOR CONDITIONAL APPROVAL OF ATALUREN FOR NONSENSE MUTATION DUCHENNE MUSCULAR DYSTROPHY SOUTH PLAINFIELD, NJ – January 24, 2014 – PTC Therapeutics, Inc. (NASDAQ: PTCT) (PTC) today announced that the Committee for Medicinal Products for Human
Additional Formats
Jan 24, 2014
SOUTH PLAINFIELD, NJ – January 24, 2013 – PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced an expansion of its senior management team with the appointment of Robert J. Spiegel M.D., FACP to Chief Medical Officer and Murad Husain to Vice President, Global Regulatory Affairs.
Additional Formats
Jan 22, 2014
SOUTH PLAINFIELD, NJ, JANUARY 22, 2014 - PTC Therapeutics, Inc. (NASDAQ: PTCT), the SMA Foundation, and Roche (SIX: RO, ROG; OTCQX: RHHBY), announced today that their joint research program in Spinal Muscular Atrophy (SMA) has entered the first stage of clinical development aiming to assess safety
Additional Formats
Jan 06, 2014
PTC Therapeutics to Present at the J.P. Morgan Healthcare Conference SOUTH PLAINFIELD, NJ – January 6, 2014 – PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that the company will present a company overview at the 2014 J.P. Morgan Healthcare Conference on Monday, January 13 at 3:00
Additional Formats
Dec 23, 2013
  SOUTH PLAINFIELD, NJ – December 23, 2013 – PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that it has been selected for addition to the NASDAQ Biotechnology Index® (Nasdaq: NBI), effective prior to the market open today. The NASDAQ Biotechnology Index is designed to track the performance
Additional Formats
Dec 12, 2013
- Data Published in PLOS ONE -
Additional Formats
Nov 14, 2013
-- Conference call to be held today at 8:00 a.m. ET --
Additional Formats
Supporting Materials
Nov 07, 2013
    SOUTH PLAINFIELD, NJ – November 7, 2013 – PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that PTC management will host a webcast conference call to discuss financial results for the third quarter ended September 30, 2013 and provide a corporate update on Thursday, November 14, 2013 at
Additional Formats